De Novo Lipogenesis and Insulin Sensitivity in Obese

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

March 11, 2022

Study Completion Date

March 11, 2022

Conditions
Insulin ResistanceObesity
Interventions
BEHAVIORAL

Fasting/refeeding

2-days fasting followed by 2-days of refeeding. During the fasting period the subjects will be hospitalized to control their state of health and ensure fasting compliance. During refeeding the standardized meals will be provided to cover individual daily requirements (60% carbohydrates, 15% protein, 25 % fat).

BEHAVIORAL

Fasting/refeeding

2-days fasting followed by 2-days of refeeding. During the fasting period the subjects will be hospitalized to control their state of health and ensure fasting compliance. During refeeding the standardized meals will be provided to cover individual daily requirements (60% carbohydrates, 15% protein, 25 % fat).

BEHAVIORAL

Ketogenic diet/ fasting

1 month of fasting-mimicking ketogenic diet and subsequent 2-days of refeeding. The subjects will be instructed by nutritional specialist to follow isocaloric ketogenic diet consisting of 6% carbohydrates, 17 % of proteins and 77% fat to cover individual energy demand. During refeeding the standardized meals will be provided to cover individual daily requirements (60% carbohydrates, 15% protein, 25 % fat).

Trial Locations (2)

100 00

Charles University, Prague

Unknown

Faculty Hospital Kralovske Vinohrady, Prague

All Listed Sponsors
collaborator

Faculty Hospital Kralovske Vinohrady

OTHER_GOV

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

Charles University, Czech Republic

OTHER

NCT04260542 - De Novo Lipogenesis and Insulin Sensitivity in Obese | Biotech Hunter | Biotech Hunter